Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Rigosertib Oral in Transfusion Dependent Lower Risk Myelodysplastic Syndromes (LR-MDS): Optimization of Dose and Rate of Transfusion Independence (TI) or Transfusion Reduction (TR) in a Single-Arm Phase 2 Study

Azra Raza, MD, Aref Al-Kali, MD, Raoul Tibes, MD PhD, Gary Spitzer, MD, Manila Gaddh, MD, Benjamin Tycko, MD PhD, Sangmin Lee, MD, Naomi Galili, PhD, Abdullah Mahmood Ali, PhD, John G. Mears, MD, Siddhartha Mukherjee, MD PhD, Ryan Shelton, BS, Steven M. Fruchtman, MD, Michael E. Petrone, MD MPH, Patrick S. Zbyszewski, MBA, Mark Lawrence Heaney, MD PhD

Blood (2017) 130 (Supplement 1): 1689.

https://doi.org/10.1182/blood.V130.Suppl_1.1689.1689

Published: 2017

Journal Articles

Emergence of a Novel Clinical Entity within Myelodysplastic Syndromes Marked By Absence of Quantifiable Terminal Erythroid Differentiation, More Profound Anemia and Significantly Worse Survival across All Prognostic Risk Categories

Abdullah Mahmood Ali, PhD, Yumin Huang, Ronald F Pinheiro, MD, Fumin Xue, PhD, Jingping Hu, PhD, Nicholas Iverson, BS, Daniela Hoehn, MDPhD, Diego Coutinho, BS, Joseph Lane, MD, Christopher D. Hillyer, MD, Naomi Galili, PhD, Joseph G. Jurcic, MD, Mohandas Narla, DSc, Xiuli An, MD PhD, Azra Raza, MD

Blood (2017) 130 (Supplement 1): 4244.

https://doi.org/10.1182/blood.V130.Suppl_1.4244.4244

Published: 2017

Journal Articles

Loss of TET2 Function in Myelodysplastic Syndrome Results in Intragenic Hypermethylation and Alterations in mRNA Splicing

Allegra M Lord, Kendell Clement, Rebekka K. Schneider, MD, McConkey Marie, PhD, Michelle C. Chen, Ross L. Levine, MD, Ann Mullally, MD, Naomi Galili, PhD, Abdullah Mahmood Ali, PhD, Azra Raza, MD, Rafael Bejar, MD PhD, Alexander Meissner, PhD, Benjamin L. Ebert, MDPhD

Blood (2014) 124 (21): 775.

https://doi.org/10.1182/blood.V124.21.775.775

Published: 2014

Journal Articles

ON 01910.Na Suppresses Cyclin D1 Accumulation in trisomy 8 Myelodysplastic Syndromes Patients While Decreasing Bone Marrow CD34+ Blast Counts and Aneuploid Clone Size.

Elaine M Sloand, MD, Matthew J. Olnes, MD, PhD, Naomi Galili, PhD, Aarthi Shenoy, MD, Loretta Pfannes, Francois Wilhelm, MD, Ph.D, Barbara Weinstein, Phillip Scheinberg, MD, Jerome E. Groopman, MD, Azra Raza

Blood (2009) 114 (22): 120.

https://doi.org/10.1182/blood.V114.22.120.120

Published: 2009

Journal Articles

Coordinate Loss of a MicroRNA Mir 145 and a Protein-Coding Gene RPS14 Cooperate in the Pathogenesis of 5q- Syndrome.

Madhu Kumar, PhD, Anupama Narla, MD, Atsushi Nonami, MD, PhD, Brian Ball, Christine Chin, Cindy Chen, Jeffery Lorne Kutok, MD, PhD, Naomi Galili, PhD, Azra Raza, MD, Eyal C. Attar, MD, D. Gary GIlliland, Tyler Jacks, Benjamin L. Ebert, MD, DPhil

Blood (2009) 114 (22): 947.

https://doi.org/10.1182/blood.V114.22.947.947

Published: 2009

Journal Articles

Initial Evaluation of a 48-h Continuous Intravenous Infusion Weekly Regimen of ON 01910.Na in Advanced Myelodysplastic Syndrome (MDS).

Azra Raza, MD, Naomi Galili, PhD, Muhammad Shahzad Ali, MD, Fahad Ali, MD, Alyssa Goodman, Samir Ahmed Qasim, MD, Francois Wilhelm, MD, Ph.D

Blood (2009) 114 (22): 3815.

https://doi.org/10.1182/blood.V114.22.3815.3815

Published: 2009

Journal Articles

MD.

Zartash Gul, MD, Naomi Galili, PhD, Nishant Tageja, MD, Azra Raza, MD

Blood (2009) 114 (22): 4863.

https://doi.org/10.1182/blood.V114.22.4863.4863

Published: 2009

Journal Articles

Phase 1 Dose Escalation Study of TLK199 Tablets (Telintra), a Novel Glutathione Analog, in Myelodysplastic Syndrome.

Azra Raza, MD, Magda Melcert, MD, Naomi Galili, PhD, Scott E. Smith, MD, PhD, FACP, John E. Godwin, MD, MS, Shelby Young, RN, Lisa Meng, MS, Marsha Jones, MD, Gail L. Brown, MD, Jeffery Lancet, MD, Alan List, MD

Blood (2007) 110 (11): 1454.

https://doi.org/10.1182/blood.V110.11.1454.1454

Published: 2007

Journal Articles

Identification of RPS14 as the 5q-Syndrome Gene by RNA Interference Screen.

Benjamin L. Ebert, MD, PhD, Jennifer Pretz, Jocelyn Bosco, Cindy Y. Chang, Pablo Tamayo, PhD, Naomi Galili, PhD, Azra Raza, MD, David Root, PhD, Eyal Attar, MD, Steven R. Ellis, PhD, Todd R. Golub, MD

Blood (2007) 110 (11): 1.

https://doi.org/10.1182/blood.V110.11.1.1

Published: 2007

Journal Articles

Expression of Proliferation Related Genes in Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (AML) Patients with Resistance to Low Dose Vidaza and Thalidomide.

Naomi Galili, PhD, Benjamin L. Ebert, MD,PhD, Peter Westervelt, MD, Jessica Wasserman, Daniel Lee, MD, Fatima Z. Raza, MD, Todd R. Golub, MD, Azra Raza, MD

Blood (2006) 108 (11): 2658.

https://doi.org/10.1182/blood.V108.11.2658.2658

Published: 2006

Journal Articles

An Erythroid Differentiation Gene Expression Signature Predicts Response to Lenalidomide in Myelodysplasia.

Benjamin L. Ebert, MD, PhD, Naomi Galili, PhD, Pablo Tamayo, PhD, Raymond Mak, Jennifer Pretz, Christine Ladd-Acosta, Richard Stone, MD, Todd R. Golub, MD, Azra Raza, MD

Blood (2006) 108 (11): 2668.

https://doi.org/10.1182/blood.V108.11.2668.2668

Published: 2006

Journal Articles

MtDNA Sequence of MDS Patients Treated with CoQ10.

Eric V. Sechman, PhD, Naomi Galili, PhD, Eric Einstein, Batool Raza, Kimberly Ferrante, Azra Raza, MD

Blood (2005) 106 (11): 4912.

https://doi.org/10.1182/blood.V106.11.4912.4912

Published: 2005

Journal Articles

A Pilot Application of SELDI Serum Proteomics in Bone Marrow Failure Syndromes.

Sujith Rao Kalmadi, MD, Ron Wu, PhD, Magdalena Plasilova, PhD, Elaine Sloand, MD, Naomi Galili, PhD, Azra Raza, MD, Jaroslaw P. Maciejewski, MD, PhD

Blood (2004) 104 (11): 2822.

https://doi.org/10.1182/blood.V104.11.2822.2822

Published: 2004

NARROW

Rigosertib Oral in Transfusion Dependent Lower Risk Myelodysplastic Syndromes (LR-MDS): Optimization of Dose and Rate of Transfusion Independence (TI) or Transfusion Reduction (TR) in a Single-Arm Phase 2 Study

Emergence of a Novel Clinical Entity within Myelodysplastic Syndromes Marked By Absence of Quantifiable Terminal Erythroid Differentiation, More Profound Anemia and Significantly Worse Survival across All Prognostic Risk Categories

Loss of TET2 Function in Myelodysplastic Syndrome Results in Intragenic Hypermethylation and Alterations in mRNA Splicing

ON 01910.Na Suppresses Cyclin D1 Accumulation in trisomy 8 Myelodysplastic Syndromes Patients While Decreasing Bone Marrow CD34+ Blast Counts and Aneuploid Clone Size.

Coordinate Loss of a MicroRNA Mir 145 and a Protein-Coding Gene RPS14 Cooperate in the Pathogenesis of 5q- Syndrome.

Initial Evaluation of a 48-h Continuous Intravenous Infusion Weekly Regimen of ON 01910.Na in Advanced Myelodysplastic Syndrome (MDS).

MD.

Phase 1 Dose Escalation Study of TLK199 Tablets (Telintra), a Novel Glutathione Analog, in Myelodysplastic Syndrome.

Identification of RPS14 as the 5q-Syndrome Gene by RNA Interference Screen.

Expression of Proliferation Related Genes in Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (AML) Patients with Resistance to Low Dose Vidaza and Thalidomide.

An Erythroid Differentiation Gene Expression Signature Predicts Response to Lenalidomide in Myelodysplasia.

MtDNA Sequence of MDS Patients Treated with CoQ10.

A Pilot Application of SELDI Serum Proteomics in Bone Marrow Failure Syndromes.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only